{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:44:25Z","timestamp":1785426265204,"version":"3.56.0"},"reference-count":34,"publisher":"Vilnius University Press","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AML"],"abstract":"<jats:p>Introduction: Multiple sclerosis (MS) may present as a tumor-like, or tumefactive demyelinating lesion, that is indistinguishable clinically and radiologically from a brain tumor. This poses a diagnostic challenge.\nCase presentation: We present a case report of a 23-year-old woman who was hospitalized in the Neurosurgery Department for biopsy of a brain mass. She had been diagnosed with Hodgkin\u2019s lymphoma at the age of 12, underwent surgery and chemotherapy, and had been in remission ever since. During her annual follow-up a magnetic resonance imaging (MRI) of the brain was performed that revealed a lesion in the right temporal lobe. It was interpreted as central nervous system (CNS) lymphoma. Before arranged neurosurgical intervention, a follow-up MRI scan revealed multiple new small lesions in both hemispheres. Biopsy was not performed, and the patient was referred to the Neurology Department for clarification of the diagnosis. No abnormalities were detected in the tests performed. Cerebrospinal fluid (CSF) was not tested due to the patient\u2019s refusal to repeat the unsuccessful procedure. The patient was discharged from the hospital. Three months later she arrived at the Emergency Department abroad with impaired coordination and hypoesthesia on the right side of the body. Two MRI scans revealed a new lesion in the left posterior periventricular area. CNS lymphoma was suspected again. The patient received treatment with levetiracetam and dexamethasone. Upon her return, an MRI scan was repeated, which revealed an enlargement of the lesion. CSF testing showed indistinct oligoclonal bands. As CNS lymphoma could not be excluded, a lesion biopsy was performed after discontinuation of the steroids therapy. Histological examination excluded malignancy. Later an MRI scan was repeated that showed two new contrast-enhancing lesions. Relapsing-remitting multiple sclerosis (RRMS) diagnosis was confirmed and treatment with disease-modifying therapies (DMTs) was planned.\nConclusions: Open-ring enhancement with little or no mass effect on MRI suggests a tumefactive demyelinating lesion (TDL). Moreover, TDLs tend to have a lower relative cerebral blood volume, and higher minimum and average apparent diffusion coefficient values compared to CNS lymphomas. Flow cytometry shows a monotypic B lymphoid population in cases of CNS lymphoma, not in MS.<\/jats:p>","DOI":"10.15388\/amed.2026.33.1.20","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:35:14Z","timestamp":1784698514000},"page":"222-231","source":"Crossref","is-referenced-by-count":0,"title":["Challenges in the Diagnosis of Multiple Sclerosis: A Case Report"],"prefix":"10.15388","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6161-3001","authenticated-orcid":false,"given":"Kristina","family":"Galinyt\u0117","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0069bkg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Lithuanian University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gintar\u0117","family":"Butenyt\u0117","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0069bkg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Lithuanian University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gintar\u0117","family":"\u017demgulyt\u0117","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0069bkg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Lithuanian University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgita","family":"Mak\u0161tien\u0117","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0069bkg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Lithuanian University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8772-6810","authenticated-orcid":false,"given":"Renata","family":"Balnyt\u0117","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0069bkg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Lithuanian University of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6097","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Jakimovski D, Bittner S, Zivadinov R, Morrow SA, Benedict RH, Zipp F, et al. Multiple sclerosis. Lancet. 2024;403(10422):183-202. doi:10.1016\/S0140-6736(23)01473-3","DOI":"10.1016\/S0140-6736(23)01473-3"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Portaccio E, Magyari M, Havrdova EK, Ruet A, Brochet B, Scalfari A, et al. Multiple sclerosis: emerging epidemiological trends and redefining the clinical course. Lancet Reg Health Eur. 2024;44:100977. doi:10.1016\/j.lanepe.2024.100977","DOI":"10.1016\/j.lanepe.2024.100977"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Chen E, Barile B, Durand-Dubief F, Grenier T, Sappey-Marinier D. Multiple sclerosis clinical forms classification with graph convolutional networks based on brain morphological connectivity. Front Neurosci. 2023;17:1268860. doi:10.3389\/fnins.2023.1268860","DOI":"10.3389\/fnins.2023.1268860"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Rocca MA, Preziosa P, Barkhof F, Brownlee W, Calabrese M, De Stefano N, et al. Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis. Lancet Reg Health Eur. 2024;44:100978. doi:10.1016\/j.lanepe.2024.100978","DOI":"10.1016\/j.lanepe.2024.100978"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Filippi M, Preziosa P, Meani A, Dalla Costa G, Mesaros S, Drulovic J, et al. Performance of the 2017 and 2010 revised McDonald criteria in predicting MS diagnosis after a clinically isolated syndrome. Neurology. 2022;98(1):e1-e14. doi:10.1212\/WNL.0000000000013016","DOI":"10.1212\/WNL.0000000000013016"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173. doi:10.1016\/S1474-4422(17)30470-2","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Gait\u00e1n MI, Correale J. Multiple sclerosis misdiagnosis: a persistent problem to solve. Front Neurol. 2019;10:466. doi:10.3389\/fneur.2019.00466","DOI":"10.3389\/fneur.2019.00466"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Cavanagh JJ, Levy M. Differential diagnosis of multiple sclerosis. Presse Med. 2021;50(2):104092. doi:10.1016\/j.lpm.2021.104092","DOI":"10.1016\/j.lpm.2021.104092"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Correale J, Solomon AJ, Cohen JA, Banwell BL, Gracia F, Gyang TV, et al. Differential diagnosis of suspected multiple sclerosis: global health considerations. Lancet Neurol. 2024;23(10):1035-1049. doi:10.1016\/S1474-4422(24)00256-4","DOI":"10.1016\/S1474-4422(24)00256-4"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Turatti M, Gajofatto A, Bianchi MR, Ferrari S, Monaco S, Benedetti MD. Benign course of tumour-like multiple sclerosis: report of five cases and literature review. J Neurol Sci. 2013;324(1-2):156-162. doi:10.1016\/j.jns.2012.10.026","DOI":"10.1016\/j.jns.2012.10.026"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"illarreal JV, Abraham MJ, Acevedo JAG, Rai PK, Thottempudi N, Fang X, et al. Tumefactive multiple sclerosis (TMS): a case series of this challenging variant of MS. Mult Scler Relat Disord. 2021;48:102699. doi:10.1016\/j.msard.2020.102699","DOI":"10.1016\/j.msard.2020.102699"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Al Malik YM. Tumefactive demyelinating lesions: a literature review of recent findings. Neurosciences (Riyadh). 2024;29(3):153-160. doi:10.17712\/nsj.2024.3.20230111","DOI":"10.17712\/nsj.2024.3.20230111"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Tremblay MA, Villanueva-Meyer JE, Cha S, Tihan T, Gelfand JM. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions. J Neurol Sci. 2017;381:83-87. doi:10.1016\/j.jns.2017.08.015","DOI":"10.1016\/j.jns.2017.08.015"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Balloy G, Pelletier J, Suchet L, Lebrun C, Cohen M, Vermersch P, et al. Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients. J Neurol. 2018;265(10):2251-2259. doi:10.1007\/s00415-018-8984-7","DOI":"10.1007\/s00415-018-8984-7"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Chew SH, Achmad Sankala HB, Chew E, Md Arif MH, Mohd Zain NR, Hashim H, et al. Tumefactive demyelinating lesions versus CNS neoplasms: a comparative study. Mult Scler Relat Disord. 2023;79:104992. doi:10.1016\/j.msard.2023.104992","DOI":"10.1016\/j.msard.2023.104992"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Kesavadas T, Abraham M, Kapilamoorthy TR, Hiremath BSB, Muraleedharan A, Kumar S, et al. Combining diffusion tensor metrics and DSC perfusion imaging: can it improve the diagnostic accuracy in differentiating tumefactive demyelination from high-grade glioma? AJNR Am J Neuroradiol. 2017;38(4):685-690. doi:10.3174\/ajnr.A5089","DOI":"10.3174\/ajnr.A5089"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Mabray MC, Cohen BA, Villanueva-Meyer JE, Valles FE, Barajas RF, Rubenstein JL, et al. Performance of apparent diffusion coefficient values and conventional MRI features in differentiating tumefactive demyelinating lesions from primary brain neoplasms. AJR Am J Roentgenol. 2015;205(5):1075-1082. doi:10.2214\/AJR.14.13970","DOI":"10.2214\/AJR.14.13970"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Lin X, Yu WY, Liauw L, Chander RJ, Soon WE, Lee HY, et al. Clinicoradiologic features distinguish tumefactive multiple sclerosis from CNS neoplasms. Neurol Clin Pract. 2017;7(1):53-60. doi:10.1212\/CPJ.0000000000000319","DOI":"10.1212\/CPJ.0000000000000319"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Von Baumgarten L, Illerhaus G, Korfel A, Schlegel U, Deckert M, Dreyling M. The diagnosis and treatment of primary CNS lymphoma: an interdisciplinary challenge. Dtsch Arztebl Int. 2018;115(25):419-426. doi:10.3238\/arztebl.2018.0419","DOI":"10.3238\/arztebl.2018.0419"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Abdoli M, Freedman MS. Neuro-oncology dilemma: tumour or tumefactive demyelinating lesion. Mult Scler Relat Disord. 2015;4(6):555-566. doi:10.1016\/j.msard.2015.07.013","DOI":"10.1016\/j.msard.2015.07.013"},{"key":"ref20","unstructured":"Shahan B, Choi EY, Nieves G. Cerebrospinal fluid analysis. Am Fam Physician. 2021;103(7):422-428."},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol. 2013;70(3):311-319. doi:10.1001\/jamaneurol.2013.606","DOI":"10.1001\/jamaneurol.2013.606"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Berek K, Bsteh G, Auer M, Di Pauli F, Zinganell A, Berger T, et al. Cerebrospinal fluid findings in 541 patients with clinically isolated syndrome and multiple sclerosis: a monocentric study. Front Immunol. 2021;12:675307. doi:10.3389\/fimmu.2021.675307","DOI":"10.3389\/fimmu.2021.675307"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Montalban X, Lebrun-Fr\u00e9nay C, Oh J, Arrambide G, Moccia M, Pia Amato M, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850-865. doi:10.1016\/S1474-4422(25)00270-4","DOI":"10.1016\/S1474-4422(25)00270-4"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Nguyen-Them L, Alentorn A, Ahle G, Soussain C, Mathon B, Le Garff-Tavernier M, et al. CSF biomarkers in primary CNS lymphoma. Rev Neurol (Paris). 2023;179(3):141-149. doi:10.1016\/j.neurol.2022.06.014","DOI":"10.1016\/j.neurol.2022.06.014"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Ikeguchi R, Shimizu Y, Shimizu S, Kitagawa K. CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma. Mult Scler. 2018;24(9):1212-1223. doi:10.1177\/1352458517717804","DOI":"10.1177\/1352458517717804"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Qi F, Zhang Y, Li X, Fan J, Tan H, Quan C. Tumor or demyelination? Three tumefactive multiple sclerosis case reports and literature review. World Neurosurg. 2024;187:141-146. doi:10.1016\/j.wneu.2024.04.069","DOI":"10.1016\/j.wneu.2024.04.069"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Efendio\u011flu M, K\u0131z\u0131lay T, Erol Y\u0131ld\u0131z R, S\u00fcer D, Karaaslan Z, M\u0131s\u0131rl\u0131 CH, et al. Tumefactive demyelinating lesions: a case series of 11 patients and review of the literature. Haydarpasa Numune Med J. 2021;61(3):245-255. doi:10.14744\/hnhj.2021.59862","DOI":"10.14744\/hnhj.2021.59862"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Ongphichetmetha T, Aungsumart S, Siritho S, Apiwattanakul M, Tanboon J, Rattanathamsakul N, et al. Tumefactive demyelinating lesions: a retrospective cohort study in Thailand. Sci Rep. 2024;14(1):1-13. doi:10.1038\/s41598-024-52048-w","DOI":"10.1038\/s41598-024-52048-w"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Hjalgrim H, Rasmussen S, Rostgaard K, Nielsen NM, Koch-Henriksen N, Munksgaard L, et al. Familial clustering of Hodgkin lymphoma and multiple sclerosis. J Natl Cancer Inst. 2004;96(10):780-784. doi:10.1093\/jnci\/djh135","DOI":"10.1093\/jnci\/djh135"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Montgomery S, Hajiebrahimi M, Burkill S, Hillert J, Olsson T, Bahmanyar S. Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma. Neurol Neuroimmunol Neuroinflamm. 2016;3(3):e227. doi:10.1212\/NXI.0000000000000227","DOI":"10.1212\/NXI.0000000000000227"},{"key":"ref31","unstructured":"Hoover K, Higginbotham K. Epstein-Barr Virus. [Updates 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559285\/"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"French HD. Tumefactive multiple sclerosis versus high-grade glioma: a diagnostic dilemma. Surg Neurol Int. 2021;12:199. doi:10.25259\/SNI_901_2020","DOI":"10.25259\/SNI_901_2020"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Deisenhammer F, Hegen H, Arrambide G, Banwell BL, Coetzee T, Gnanapavan S, et al. Positive cerebrospinal fluid in the 2024 McDonald criteria for multiple sclerosis. EBioMedicine. 2025;120:105905. doi:10.1016\/j.ebiom.2025.105905","DOI":"10.1016\/j.ebiom.2025.105905"}],"container-title":["Acta medica Lituanica"],"original-title":[],"link":[{"URL":"https:\/\/zurnalai.vu.lt\/\/AML\/article\/download\/43906\/42914","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/zurnalai.vu.lt\/\/AML\/article\/download\/43906\/42939","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/zurnalai.vu.lt\/\/AML\/article\/download\/43906\/42914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:38:50Z","timestamp":1784716730000},"score":1,"resource":{"primary":{"URL":"https:\/\/zurnalai.vu.lt\/\/AML\/article\/view\/43906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,7,22]]}},"URL":"https:\/\/doi.org\/10.15388\/amed.2026.33.1.20","relation":{},"ISSN":["2029-4174","1392-0138"],"issn-type":[{"value":"2029-4174","type":"electronic"},{"value":"1392-0138","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}